Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases.

Szczegóły
Abstrakt

Tytuł:: Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases.
Autorzy:: You S; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Su X; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China.
Ying J; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China.
Li S; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China.
Qu Y; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China.
Mu D; Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China.
Źródło:: Biomolecules [Biomolecules] 2022 Aug 21; Vol. 12 (8). Date of Electronic Publication: 2022 Aug 21.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: Basel, Switzerland : MDPI, 2011-
MeSH Terms:: Nervous System Diseases*/genetics
Nervous System Diseases*/pathology
Neuroglia*
Astrocytes/pathology ; Humans ; Oligodendroglia/physiology ; RNA
References:: J Clin Invest. 2017 Sep 1;127(9):3201-3209. (PMID: 28714861)
J Neurosci Res. 2004 Mar 1;75(5):614-23. (PMID: 14991837)
Nat Commun. 2021 Jun 18;12(1):3778. (PMID: 34145251)
Front Cell Neurosci. 2013 Dec 20;7:268. (PMID: 24391545)
Genes Dev. 2018 Mar 1;32(5-6):415-429. (PMID: 29535189)
Nat Rev Dis Primers. 2018 Nov 8;4(1):43. (PMID: 30410033)
Aging (Albany NY). 2021 Aug 30;13(16):20716-20737. (PMID: 34461609)
Front Genet. 2021 Oct 13;12:743738. (PMID: 34721530)
Neuroscientist. 2019 Aug;25(4):334-343. (PMID: 30122106)
Nat Commun. 2021 Nov 26;12(1):6937. (PMID: 34836959)
Genome Biol. 2018 May 31;19(1):69. (PMID: 29855337)
Science. 2021 Oct 15;374(6565):eabh2858. (PMID: 34648330)
Curr Opin Cell Biol. 2021 Dec;73:35-40. (PMID: 34153742)
Cancer Discov. 2021 Feb;11(2):480-499. (PMID: 33023892)
J Hazard Mater. 2022 Mar 15;426:128099. (PMID: 34954437)
Cold Spring Harb Perspect Biol. 2015 Apr 15;7(6):. (PMID: 25877220)
Mol Neurobiol. 2016 Dec;53(10):6709-6715. (PMID: 26659872)
Chin Med J (Engl). 2022 Aug 04;:. (PMID: 35261352)
J Transl Med. 2021 Jul 22;19(1):316. (PMID: 34294105)
Oncogene. 2018 Jan 25;37(4):522-533. (PMID: 28991227)
Int J Biochem Cell Biol. 2004 Oct;36(10):1861-7. (PMID: 15203098)
Acta Neuropathol Commun. 2021 Mar 25;9(1):54. (PMID: 33766119)
Epigenomics. 2019 May;11(7):805-819. (PMID: 30882247)
Front Cell Neurosci. 2021 Nov 17;15:755955. (PMID: 34867201)
Front Psychiatry. 2020 Apr 30;11:379. (PMID: 32425837)
Hum Genet. 2016 Aug;135(8):851-67. (PMID: 27215579)
Nature. 2017 Jan 26;541(7638):481-487. (PMID: 28099414)
Physiol Rev. 2001 Apr;81(2):871-927. (PMID: 11274346)
Nat Neurosci. 2013 Aug;16(8):1042-8. (PMID: 23817550)
Ther Adv Chronic Dis. 2020 Apr 29;11:2040622320916024. (PMID: 32426101)
Parkinsons Dis. 2021 Dec 20;2021:9919129. (PMID: 34966539)
Eur Arch Psychiatry Clin Neurosci. 2022 Sep;272(6):947-955. (PMID: 34822006)
J Neuroinflammation. 2012 Jun 29;9:149. (PMID: 22747686)
Cells. 2021 Dec 31;11(1):. (PMID: 35011695)
Cancer Res. 2019 Nov 15;79(22):5785-5798. (PMID: 31530567)
Acta Neuropathol. 2015 Jun;129(6):829-48. (PMID: 25943888)
J Affect Disord. 2015 Sep 01;183:279-86. (PMID: 26047305)
Int Immunopharmacol. 2020 Nov;88:106937. (PMID: 32890792)
PLoS Genet. 2021 Mar 8;17(3):e1009086. (PMID: 33684100)
Glia. 2020 Jul;68(7):1421-1434. (PMID: 32036619)
Trends Neurosci. 2019 Apr;42(4):263-277. (PMID: 30770136)
Neuroscientist. 2019 Jun;25(3):227-240. (PMID: 29931997)
Int J Mol Sci. 2021 Apr 26;22(9):. (PMID: 33926120)
Cell Rep. 2021 Mar 23;34(12):108882. (PMID: 33761343)
Mol Neurodegener. 2021 Sep 30;16(1):70. (PMID: 34593014)
Nucleic Acids Res. 2018 Feb 16;46(3):1412-1423. (PMID: 29186567)
Annu Rev Cell Dev Biol. 2014;30:439-63. (PMID: 25288116)
Cancer Sci. 2021 Nov;112(11):4543-4552. (PMID: 34390075)
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. (PMID: 31520073)
Int J Mol Sci. 2021 Feb 06;22(4):. (PMID: 33561958)
Mol Brain. 2020 Jan 28;13(1):11. (PMID: 31992337)
Neuropsychiatr Dis Treat. 2015 Jan 08;11:97-106. (PMID: 25657582)
Mol Cell. 2016 Feb 18;61(4):507-519. (PMID: 26876937)
Cell Death Discov. 2021 Oct 13;7(1):292. (PMID: 34645788)
Nat Rev Dis Primers. 2017 Mar 23;3:17013. (PMID: 28332488)
Nat Commun. 2021 Jan 8;12(1):177. (PMID: 33420027)
Trends Cell Biol. 2018 Feb;28(2):113-127. (PMID: 29103884)
J Cell Biol. 2018 Feb 5;217(2):459-472. (PMID: 29196460)
Nat Rev Mol Cell Biol. 2017 Jan;18(1):31-42. (PMID: 27808276)
Stroke. 2019 Oct;50(10):2912-2921. (PMID: 31436138)
Cell Death Dis. 2022 Jan 21;13(1):73. (PMID: 35064112)
Neurochem Int. 2021 Sep;148:105080. (PMID: 34048845)
Prog Neurobiol. 2017 Oct;157:247-272. (PMID: 26851161)
Cancers (Basel). 2020 Dec 25;13(1):. (PMID: 33375621)
Behav Brain Res. 2021 May 21;406:113227. (PMID: 33677012)
J Extracell Vesicles. 2020 Dec;10(2):e12035. (PMID: 33408815)
J Clin Psychiatry. 2015 Nov;76(11):e1480. (PMID: 26646047)
Int J Mol Sci. 2021 Sep 24;22(19):. (PMID: 34638653)
RNA. 2018 Apr;24(4):499-512. (PMID: 29348140)
Dev Neurobiol. 2022 Mar;82(2):160-174. (PMID: 35081276)
Mol Psychiatry. 2013 Dec;18(12):1281-6. (PMID: 23164817)
Int J Mol Sci. 2019 Jun 06;20(11):. (PMID: 31174279)
Glia. 2019 May;67(5):779-790. (PMID: 30240060)
Nat Immunol. 2021 May;22(5):586-594. (PMID: 33859405)
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109736. (PMID: 31425724)
Nat Rev Immunol. 2019 Sep;19(9):539-549. (PMID: 31019284)
Cell Mol Neurobiol. 2022 Jan 23;:. (PMID: 35066715)
Front Oncol. 2020 Mar 09;10:208. (PMID: 32211315)
Neuron. 2018 Jul 25;99(2):389-403.e9. (PMID: 30048615)
Cell. 2007 Dec 14;131(6):1164-78. (PMID: 18083105)
Cell Mol Life Sci. 2013 Nov;70(22):4355-68. (PMID: 23689590)
ACS Chem Neurosci. 2019 May 15;10(5):2355-2363. (PMID: 30835997)
Cancer Res. 2021 Dec 1;81(23):5876-5888. (PMID: 34670781)
Cell Death Dis. 2020 Sep 30;11(9):816. (PMID: 32999283)
Mol Cancer. 2019 May 29;18(1):103. (PMID: 31142332)
Cell Discov. 2018 Feb 27;4:10. (PMID: 29507755)
Neurobiol Stress. 2021 Sep 04;15:100390. (PMID: 34527794)
Cell Biol Toxicol. 2021 Jun 16;:. (PMID: 34132932)
Cancer Cell. 2017 Apr 10;31(4):591-606.e6. (PMID: 28344040)
Neuron. 2018 Jul 25;99(2):283-292.e5. (PMID: 30056831)
Annu Rev Immunol. 2017 Apr 26;35:441-468. (PMID: 28226226)
Hum Mol Genet. 2017 Jul 1;26(13):2398-2411. (PMID: 28398475)
Neurobiol Dis. 2020 Oct;144:105028. (PMID: 32736085)
J Neuroinflammation. 2017 May 10;14(1):102. (PMID: 28486969)
Transl Neurodegener. 2020 Nov 26;9(1):42. (PMID: 33239064)
Science. 2010 Nov 5;330(6005):779-82. (PMID: 21051629)
Cell Res. 2019 Jan;29(1):23-41. (PMID: 30514900)
Genome Biol. 2021 Jan 28;22(1):51. (PMID: 33509238)
Mol Psychiatry. 2021 Dec;26(12):7141-7153. (PMID: 34663904)
Front Oncol. 2021 Jul 15;11:702983. (PMID: 34336690)
Development. 2015 Nov 15;142(22):3805-9. (PMID: 26577203)
Trends Mol Med. 2019 Feb;25(2):112-123. (PMID: 30578090)
J Neurosci. 2017 Mar 15;37(11):2878-2894. (PMID: 28193696)
Biol Psychiatry. 2020 Sep 1;88(5):392-404. (PMID: 32387133)
Ann Transl Med. 2021 Aug;9(15):1241. (PMID: 34532378)
Cells. 2019 Nov 12;8(11):. (PMID: 31726662)
Cell. 2017 Nov 2;171(4):877-889.e17. (PMID: 28965759)
Genes (Basel). 2019 Feb 13;10(2):. (PMID: 30781903)
J Exp Med. 2021 Sep 6;218(9):. (PMID: 34292315)
J Neurol. 2019 Nov;266(11):2878-2889. (PMID: 31563989)
Glia. 2016 Jan;64(1):76-89. (PMID: 26295445)
Cells. 2020 Jul 17;9(7):. (PMID: 32709045)
J Mol Neurosci. 2021 Oct;71(10):2107-2115. (PMID: 33580473)
Front Mol Neurosci. 2020 Jun 05;13:103. (PMID: 32581712)
Nat Rev Drug Discov. 2022 May;21(5):339-358. (PMID: 35173313)
Nat Genet. 2021 Aug;53(8):1156-1165. (PMID: 34211177)
J Hematol Oncol. 2021 Jul 10;14(1):109. (PMID: 34246306)
Am J Cancer Res. 2022 Feb 15;12(2):893-906. (PMID: 35261810)
eNeuro. 2020 Sep 8;7(5):. (PMID: 32847866)
Neuron. 2020 Jan 22;105(2):293-309.e5. (PMID: 31901304)
Eur Arch Psychiatry Clin Neurosci. 2022 Sep;272(6):929-945. (PMID: 34595576)
Nat Rev Immunol. 2012 Sep;12(9):623-35. (PMID: 22903150)
ACS Chem Neurosci. 2021 Oct 20;12(20):3818-3828. (PMID: 34491720)
Cell Rep. 2019 Jul 23;28(4):845-854.e5. (PMID: 31340148)
Glia. 2022 Apr;70(4):650-660. (PMID: 34936134)
Cell Death Dis. 2020 Nov 13;11(11):977. (PMID: 33188203)
Front Cell Dev Biol. 2022 Jan 24;9:659228. (PMID: 35141227)
Cell Rep. 2017 Mar 14;18(11):2622-2634. (PMID: 28297667)
Aging (Albany NY). 2021 Oct 27;13(21):24086-24100. (PMID: 34705667)
Trends Neurosci. 2021 Feb;44(2):97-109. (PMID: 33190930)
Trends Immunol. 2021 Nov;42(11):937-939. (PMID: 34657802)
Nucleic Acids Res. 2021 Jan 8;49(D1):D134-D143. (PMID: 32821938)
Mol Neurobiol. 2014 Jun;49(3):1117-25. (PMID: 24243343)
Acad Emerg Med. 2016 Jul;23(7):786-9. (PMID: 27018399)
Contributed Indexing:: Keywords: RNA m6A modification; astrocyte; microglia; neurological disease; oligodendrocyte
Substance Nomenclature:: 63231-63-0 (RNA)
Entry Date(s):: Date Created: 20220826 Date Completed: 20220829 Latest Revision: 20220913
Update Code:: 20240105
PubMed Central ID:: PMC9405963
DOI:: 10.3390/biom12081158
PMID:: 36009052
: Czasopismo naukowe

Pełny tekst

Glial cells are the most abundant and widely distributed cells that maintain cerebral homeostasis in the central nervous system. They mainly include microglia, astrocytes, and the oligodendrocyte lineage cells. Moreover, glial cells may induce pathological changes, such as inflammatory responses, demyelination, and disruption of the blood-brain barrier, to regulate the occurrence and development of neurological diseases through various molecular mechanisms. Furthermore, RNA m6A modifications are involved in various pathological processes associated with glial cells. In this review, the roles of glial cells in physiological and pathological states, as well as advances in understanding the mechanisms by which glial cells regulate neurological diseases under RNA m6A modification, are summarized, hoping to provide new perspectives on the deeper mechanisms and potential therapeutic targets for neurological diseases.

Informacja